For all searches and for all browse results, select the Search button at the bottom after you have refined your criteria.
Phase I clinical trials are typically not disease specific and can be searched separately by clicking on the Phase I checkbox. (If you do not select Phase I, trials in any phase that match your other search terms will be retrieved.)
Phase II clinical trials continue to test the safety of the drug, and begins to evaluate how well the new drug works. Phase II studies usually focus on a particular type of cancer.
Phase III clinical trial studies test a new drug, a new combination of drugs, or a new surgical procedure in comparison to the current standard. A participant will usually be assigned to the standard group or the new group at random (called randomization). Phase III trials often enroll large numbers of people and may be conducted at many doctors' offices, clinics, and cancer centers nationwide.
Cancer Prevention clinical trials test whether taking certain medicines, vitamins, minerals, or food supplements may lower the risk of a certain type of cancer.
Cancer Control clinical trials test whether certain drugs reduce side effects from chemotherapy and other primary treatments.
For more information on clinical trials at the Karmanos Cancer Institute, please e-mail firstname.lastname@example.org or call (800) KARMANOS (1-800-527-6266).
For more information on clinical trials (general), please visit www.Cancer.gov or www.CancerTrialsHelp.org.